Houra Merrikh
-
Vanderbilt’s Life Science Showcase focuses on cutting-edge infectious disease research
Infectious diseases pose a significant global health challenge, accounting for a substantial proportion of deaths worldwide, according to recent data from the World Health Organization. Vanderbilt’s Life Science Showcase: Advancing Innovation in Infectious Diseases held on July 18 emphasized the vital importance of advancing research and innovation to combat these persistent threats. Read MoreJul 23, 2024
-
Vanderbilt biochemists discover breakthrough evolution-resistant compound to combat antibiotic resistance
Vanderbilt scientist Houra Merrikh led a team of researchers who discovered the first evolution-resistant chemical compound that prevents drug resistance development in bacteria. The compound is also a drug development platform that targets antimicrobial resistance during treatment of infections with antibiotics and evolution in general, Merrikh said. Read MoreMar 1, 2024
-
Vanderbilt biochemists discover breakthrough anti-evolution compound to combat antibiotic resistance
The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read MoreFeb 26, 2024
-
CLASS OF 2024: Discovery and communication key to biochemistry Ph.D. Kaitlyn Browning
WATCH: See how Ph.D. candidate Kaitlyn Browning wants to fight miscommunication and misinformation around science. Read MoreFeb 16, 2024
-
Foundation funds research to block drug resistance in cancer treatment
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance. Read MoreSep 5, 2023
-
Cohen Innovation Fund Awards Announced Supporting Two High-Risk, High-Reward Projects
Houra Merrikh, professor of biochemistry, and Teru Nakagawa, associate professor of molecular physiology and biophysics, have both been selected to receive one-year research awards from the Stanley Cohen Innovation Fund. The awards will support groundbreaking and paradigm-shifting research. Read MoreSep 28, 2021
-
Merrikh named finalist for Blavatnik National Award for Young Scientists for second year
For the second year in a row, Professor of Biochemistry Houra Merrikh has been named a finalist for the 2021 Blavatnik National Awards for Young Scientists in the life sciences category for her discovery of a potential solution to prevent the evolution of antimicrobial resistance and, in some cases, even reverse existing resistance. Read MoreJun 17, 2021
-
Vanderbilt researcher Houra Merrikh named a finalist of the 2020 Blavatnik National Awards for Young Scientists, inducted to New York Academy of Sciences
Biochemist Houra Merrikh has been named one of the nation’s rising stars in science for her work to reverse antimicrobial resistance. Read MoreJun 17, 2020
-
New faculty Houra Merrikh: On a collision course with antibiotic resistance
Professor of Biochemistry Houra Merrikh distinctly remembers the day the email showed up in her inbox. Sent from the Bill and Melinda Gates Foundation, it was an invitation to present her research to someone named “Bill”—no last name included—in two days’ time. Read MoreSep 29, 2019
-
Rokas to lead budding cross-disciplinary collaboration on evolutionary studies
The Vanderbilt Evolutionary Studies Initiative seeks to position the university as a global leader in evolutionary studies by engaging a large group of scholars who share this research interest. Read MoreAug 14, 2019